J B Chemicals and Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live

The approved product is the generic version of Zebeta (marketed by Teva Pharmaceuticals) and is indicated for the management of hypertension. JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates. The company's consolidated net profit jumped 21.7% to Rs 162.49 crore on a 14.1% rise in net sales to Rs 963.49 crore in Q3 FY25 over Q3 FY24. Shares of JB Chemicals & Pharmaceuticals rose 0.47% to Rs 1,652.95 on the BSE.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA), Bisoprolol Tablets USP, 5 mg, and 10 mg, the generic version of Zebeta (Teva), which is indicated in the management of hypertension.Powered by Capital Market - Live

Capri Global Capital Ltd, RHI Magnesita India Ltd, Gujarat Pipavav Port Ltd, MMTC Ltd are among the other stocks to see a surge in volumes on NSE today, 27 March 2025.J B Chemicals & Pharmaceuticals Ltd witnessed volume of 110.79 lakh shares by 14:14 IST on NSE, a 96.3 times surge over two-week average daily volume of 1.15 lakh shares. The stock dropped 5.32% to Rs.1,617.85. Volumes stood at 75510 shares in the last session.Capri Global Capital Ltd witnessed volume of 1106.42 lakh shares by 14:14 IST on NSE, a 18.26 times surge over two-week average daily volume of 60.60 lakh shares. The stock dropped 13.43% to Rs.168.70. Volumes stood at 467.18 lakh shares in the last session.RHI Magnesita India Ltd witnessed volume of 154.53 lakh shares by 14:14 IST on NSE, a 12.41 times surge over two-week average daily volume of 12.46 lakh shares. The stock increased 10.18% to Rs.512.50. Volumes stood at 1.74 lakh shares in the last session.Gujarat Pipavav Port Ltd recorded volume of 129.28 lakh shares by 14:14 IST on NSE, a 7.05 times surge over two-week average daily volume of 18.32 lakh shares. The stock gained 5.79% to Rs.142.26. Volumes stood at 11.18 lakh shares in the last session.MMTC Ltd witnessed volume of 111.59 lakh shares by 14:14 IST on NSE, a 5.42 times surge over two-week average daily volume of 20.60 lakh shares. The stock increased 6.40% to Rs.55.85. Volumes stood at 29.33 lakh shares in the last session.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals has allotted 1,700 equity shares under ESOS on 18 March 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,75,508 equity shares of Re. 1 each to 15,56,77,208 equity shares of Re. 1 each.Powered by Capital Market - Live

The inspection, conducted from 10 March to 13 March 2025, concluded with no Form 483 issued. 'The company said that it remains committed to producing quality products, embedding a quality culture across the organization, and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets.' JB Chemicals stated. JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates. The company's consolidated net profit jumped 21.7% to Rs 162.49 crore on a 14.1% rise in net sales to Rs 963.49 crore in Q3 FY25 over Q3 FY24. Shares of JB Chemicals & Pharmaceuticals rose 0.88% to end at Rs 1,518 on Thursday, 13 March 2025.Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals Ltd fell 3.64% today to trade at Rs 1450. The BSE Healthcare index is down 0.33% to quote at 39246.76. The index is down 4.3 % over last one month. Among the other constituents of the index, Orchid Pharma Ltd decreased 2.55% and Jupiter Life Line Hospitals Ltd lost 1.43% on the day. The BSE Healthcare index went up 16.34 % over last one year compared to the 1.9% surge in benchmark SENSEX. J B Chemicals & Pharmaceuticals Ltd has lost 10.02% over last one month compared to 4.3% fall in BSE Healthcare index and 2.82% drop in the SENSEX. On the BSE, 724 shares were traded in the counter so far compared with average daily volumes of 3369 shares in the past one month. The stock hit a record high of Rs 2029 on 16 Aug 2024. The stock hit a 52-week low of Rs 1448.6 on 13 Mar 2025.Powered by Capital Market - Live

The inspection was conducted from 3 March 2025 to 7 March 2025. The said audit has been successfully completed by the US FDA with 'no observations' and thus no Form 483 was issued. Following this announcement, the scrip advanced 1.43% to currently trade at Rs 1599.95 on the BSE. The company remains committed to producing quality products, embedding a quality culture across the organization and continuously investing in systems, processes & training of its employees so that it can maintain the highest standards of quality and compliance for all its markets,' JB Chemicals stated. JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates. Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals has allotted 69,180 equity shares under ESOS on 27 February 2025. Consequently, the issued, subscribed and paid up capital has increased from 15,56,06,328 equity shares of Re. 1 each to 15,56,75,508 equity shares of Re. 1 each. Powered by Capital Market - Live

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 4 February 2025, inter alia, have recommended the interim dividend of Rs 8.5 per equity Share (i.e. 850%) , subject to the approval of the shareholders.Powered by Capital Market - Live